ToDx
Developer of lab-quality, single-use molecular diagnostic tests designed for use at the point-of-need (home or clinic). Focused initially on rapid detection of STIs (Chlamydia, Gonorrhea, Trichomonas) with smartphone-based result interpretation, the company aims to adapt its oligonucleotide marker–based assay platform to broader infectious-disease and syndromic testing.
Industries
Nr. of Employees
small (1-50)
Products
Single-use molecular diagnostic kit for STIs
A disposable molecular test kit designed to detect Chlamydia, Gonorrhea, and Trichomonas from urine, oral, or rectal swabs with smartphone-based interpretation and rapid turnaround.
ToDx single-use molecular diagnostic kit
A single-use molecular diagnostic kit that detects Chlamydia, Gonorrhea, and Trichomonas within minutes, requiring only a smartphone for result interpretation. It uses lab-quality molecular methods for high sensitivity and specificity at the point of need, with built-in safeguards to reduce errors.
Single-use molecular diagnostic kit for STIs
A disposable molecular test kit designed to detect Chlamydia, Gonorrhea, and Trichomonas from urine, oral, or rectal swabs with smartphone-based interpretation and rapid turnaround.
ToDx single-use molecular diagnostic kit
A single-use molecular diagnostic kit that detects Chlamydia, Gonorrhea, and Trichomonas within minutes, requiring only a smartphone for result interpretation. It uses lab-quality molecular methods for high sensitivity and specificity at the point of need, with built-in safeguards to reduce errors.
Services
Provision of molecular diagnostic testing workflows and kits designed for use by patients at home or by clinicians at point-of-care sites to enable rapid diagnosis.
Development and extension of the core molecular assay platform to additional infectious targets and syndromic panels.
Software and workflow enabling result interpretation via smartphone to remove the need for separate reading devices.
Provision of molecular diagnostic testing workflows and kits designed for use by patients at home or by clinicians at point-of-care sites to enable rapid diagnosis.
Development and extension of the core molecular assay platform to additional infectious targets and syndromic panels.
Software and workflow enabling result interpretation via smartphone to remove the need for separate reading devices.
Expertise Areas
- Molecular diagnostics
- Point-of-care and at-home testing
- Assay development for oligonucleotide markers
- Smartphone-based diagnostic interpretation
Key Technologies
- Nucleic acid (oligonucleotide) marker assays
- Point-of-care molecular diagnostics
- Single-use disposable assay formats
- Smartphone-based readout and interpretation